Cargando…
Generation of a CD70-Specific Fusion Nanobody with IgG Recruiting Capacity for Tumor Killing
PURPOSE: Due to its competitive advantages such as small size, high stability, easy production, and good tissue penetration compared with monoclonal antibodies (mAb), nanobodies (Nbs) were considered the next generation of therapeutics. However, the absence of Fc fragments and Fc-triggered immune ef...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289098/ https://www.ncbi.nlm.nih.gov/pubmed/37361386 http://dx.doi.org/10.2147/IJN.S410281 |